Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging

Sean J Hipp1, Emilie Steffen-Smith, Dima Hammoud

  • 1Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA. sean.hipp@us.army.mil

Neuro-Oncology
|July 16, 2011
PubMed

Insights

Dynamic susceptibility contrast MRI and single-voxel spectroscopy can predict survival in children with diffuse intrinsic pontine gliomas (DIPG). Increased perfusion and specific metabolite ratios on MRI indicate shorter survival for DIPG patients.

Area of Science:

  • Pediatric Oncology
  • Neuroradiology
  • Medical Imaging

Background:

  • Magnetic resonance imaging (MRI) is crucial for assessing pediatric diffuse intrinsic pontine gliomas (DIPGs).
  • Currently, no standard MRI sequence reliably predicts outcomes in DIPG patients.
  • There is a need for prognostic imaging biomarkers in DIPG management.

Purpose of the Study:

  • To evaluate the combined prognostic value of dynamic susceptibility contrast (DSC) MRI, single-voxel spectroscopy (SVS), multivoxel MR spectroscopy (MRS), and T1-weighted post-gadolinium imaging in children with DIPG.
  • To identify specific MRI parameters that correlate with patient survival.

Main Methods:

  • Retrospective analysis of 98 MRI studies from 34 children diagnosed with DIPG.
  • Utilized DSC-MRI, SVS, MRS, and post-gadolinium T1-weighted imaging at various time points.
  • Statistical evaluation included Cox proportional hazard models, time-dependent covariant Cox models, Wald tests, and Kaplan-Meier analysis.

Main Results:

  • Increased choline to n-acetylaspartate ratio (Cho:NAA) on SVS and increased perfusion on DSC-MRI at baseline predicted shorter survival.
  • At subsequent time points, increased maximum Cho:NAA on MRS, increased Cho:NAA on SVS, increased perfusion, and presence of enhancement were associated with shorter survival.
  • Increased perfusion at any time point was a significant predictor of shorter survival (P = .0004 at baseline).

Conclusions:

  • Dynamic susceptibility contrast MRI and single-voxel spectroscopy are valuable prognostic tools for children with DIPG.
  • Routine baseline and follow-up imaging should incorporate DSC-MRI and SVS to assess DIPG patient outcomes.
  • Enhancement and specific metabolic changes (Cho:NAA) also provide prognostic information over time.

Related Concept Videos